Abstract:Current pharmacological treatments for depression fail to produce adequate remission in a significant proportion of patients. Increasingly, other systems, such as the microbiome–gut–brain axis, are being looked at as putative novel avenues for depression treatment. Dysbiosis and dysregulation along this axis are highly comorbid with the severity of depression symptoms. The endogenous extracellular matrix protein reelin is present in all intestinal layers as well as in myenteric and submucosal ganglia, and its receptors are also present in the gut. Reelin secretion from subepithelial myofibroblasts regulates cellular migration along the crypt–villus axis in the small intestine and colon. Reelin brain expression is downregulated in mood and psychotic disorders, and reelin injections have fast antidepressant-like effects in animal models of depression. This review seeks to discuss the roles of reelin in the gastrointestinal system and propose a putative role for reelin actions in the microbiota–gut–brain axis in the pathogenesis and treatment of depression, primarily reflecting on alterations in gut epithelial cell renewal and in the clustering of serotonin transporters.

What problem does this paper attempt to address?

The paper primarily explores the molecular mechanisms of Reelin protein in the Enteric Nervous System (ENS) and the Microbiota-Gut-Brain Axis (MGB Axis), and discusses the relationship between these mechanisms and depression and its treatment. ### Problems the Paper Attempts to Address 1. **Role of Reelin Protein in the ENS**: Investigate how Reelin protein regulates processes such as cell migration, intestinal epithelial cell renewal, and intestinal barrier integrity in the ENS. 2. **Relationship between Reelin Protein and the MGB Axis**: Explore how Reelin protein participates in the occurrence and development of depression by affecting the interactions between the microbiota, gut, and brain. 3. **Potential of Reelin Protein as a Target for Depression Treatment**: Given that Reelin protein levels are downregulated in patients with depression and it has a rapid antidepressant effect, evaluate the potential of Reelin protein as a novel target for antidepressant treatment. ### Research Background - Current antidepressant medications have limited efficacy for many patients, prompting researchers to seek new treatment avenues. - Studies on the gut microbiome-gut-brain axis show a connection between gut health and depression. - Reelin protein is an important extracellular matrix protein that plays a key role in brain development; its expression is reduced in patients with depression, and restoring its normal levels can produce rapid antidepressant effects. ### Main Findings - Reelin protein is present throughout the intestinal layers and is expressed in intestinal ganglia and lymphatic vessels. - Reelin protein may promote normal renewal of the intestinal mucosa by regulating the migration of intestinal epithelial cells along the crypt-villus axis. - Reelin protein may also help maintain the integrity of the intestinal barrier and participate in the renewal and differentiation of intestinal stem cells. - In depression, Reelin protein may be involved in the development of the disease through mechanisms such as affecting intestinal epithelial cell renewal and serotonin transporter aggregation. ### Conclusion This paper aims to provide a comprehensive overview of the mechanisms of Reelin protein in the gut and proposes that Reelin protein may influence the pathogenesis and treatment of depression through its functions in the microbiota-gut-brain axis. Although current research on the role of Reelin protein in the gut and gastrointestinal dysfunction is limited, this review provides direction for future research to explore the potential role of Reelin protein in depression.

Implications for Depression and Antidepressant Therapy

Epigenetics in depression and gut-brain axis: A molecular crosstalk

Reelin-Related Disturbances in Depression: Implications for Translational Studies

A review of the antimicrobial side of antidepressants and its putative implications on the gut microbiome

Intestinal Barrier, Immunity and Microbiome: Partners in the Depression Crime

Gut microbiota–brain axis in depression: The role of neuroinflammation

Mood and microbes: a comprehensive review of intestinal microbiota's impact on depression

Gut-to-brain axis provides novel therapeutic targets for depression

A Reciprocal Link Between Gut Microbiota, Inflammation and Depression: A Place for Probiotics?

Inflammation, Lifestyle Factors, and the Microbiome‐Gut‐Brain Axis: Relevance to Depression and Antidepressant Action

“I Am I and My Bacterial Circumstances”: Linking Gut Microbiome, Neurodevelopment, and Depression

Baseline gut microbiota profiles affect treatment response in patients with depression

Gut-brain axis: A matter of health and disease in neuropsychiatric disorders…!

Gut Microorganisms, Neuroinflammation and Behavioral Changes

Prebiotic and Probiotic Modulation of the Microbiota–Gut–Brain Axis in Depression

The bidirectional interaction between antidepressants and the gut microbiota: are there implications for treatment response?

Mechanistic Insights into the Link between Gut Dysbiosis and Major Depression: An Extensive Review

Potential role of gut microbiota in major depressive disorder: A review

The Role of the Gut Microbiota in the Development and Progression of Major Depressive and Bipolar Disorder

The Role of Microbiota in Depression - a brief review

Probiotics and the Microbiota-Gut-Brain Axis: Focus on Psychiatry